Scarica l'app Stockscreener
1.94
0.52%
0.01
Pre-mercato:
1.95
0.01
+0.52%
Milestone Pharmaceuticals Inc Azioni (MIST) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Research and Development |
26.30%
3.669
|
4.978 | 3.94 | 3.963 | 2.815 |
| Operating Income/Loss |
38.94%
-12.53
|
-20.52 | -12.35 | -9.616 | -9.662 |
| Income/Loss From Continuing Operations Before Tax |
37.55%
-12.97
|
-20.76 | -12.36 | -9.439 | -9.363 |
| Income/Loss From Continuing Operations After Tax |
37.55%
-12.97
|
-20.76 | -12.36 | -9.439 | -9.363 |
Net Income/Loss
|
37.55%
-12.97
|
-20.76 | -12.36 | -9.439 | -9.363 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Earnings Per Share |
35.48%
-0.20
|
-0.31 | -0.19 | -0.14 | -0.14 |
| Diluted Earnings Per Share |
35.48%
-0.20
|
-0.31 | -0.19 | -0.14 | -0.14 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.30%
2.51%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):